BioCryst Pharmaceuticals Inc (BCRX)
4.57
+0.44
(+10.65%)
USD |
NASDAQ |
May 01, 16:00
4.565
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Price: 4.57 for May 1, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 01, 2024 | 4.18 | 4.77 | 4.15 | 4.57 | 3.955M |
Apr 30, 2024 | 4.20 | 4.26 | 4.11 | 4.13 | 2.938M |
Apr 29, 2024 | 4.20 | 4.35 | 4.145 | 4.27 | 3.025M |
Apr 26, 2024 | 4.21 | 4.26 | 4.11 | 4.16 | 2.311M |
Apr 25, 2024 | 4.15 | 4.17 | 4.03 | 4.16 | 2.736M |
Apr 24, 2024 | 4.37 | 4.42 | 4.18 | 4.21 | 4.410M |
Apr 23, 2024 | 4.44 | 4.63 | 4.37 | 4.38 | 4.237M |
Apr 22, 2024 | 4.43 | 4.57 | 4.39 | 4.41 | 2.557M |
Apr 19, 2024 | 4.50 | 4.59 | 4.27 | 4.43 | 4.694M |
Apr 18, 2024 | 4.60 | 4.71 | 4.49 | 4.50 | 2.960M |
Apr 17, 2024 | 4.65 | 4.79 | 4.57 | 4.58 | 4.055M |
Apr 16, 2024 | 4.61 | 4.72 | 4.54 | 4.61 | 1.979M |
Apr 15, 2024 | 4.78 | 4.785 | 4.59 | 4.67 | 2.497M |
Apr 12, 2024 | 5.10 | 5.16 | 4.70 | 4.77 | 4.526M |
Apr 11, 2024 | 4.93 | 5.115 | 4.82 | 5.10 | 3.304M |
Apr 10, 2024 | 4.64 | 4.905 | 4.56 | 4.87 | 2.915M |
Apr 09, 2024 | 4.61 | 4.88 | 4.61 | 4.80 | 1.974M |
Apr 08, 2024 | 4.62 | 4.67 | 4.54 | 4.61 | 1.605M |
Apr 05, 2024 | 4.56 | 4.66 | 4.45 | 4.60 | 1.785M |
Apr 04, 2024 | 4.76 | 4.84 | 4.58 | 4.60 | 2.737M |
Apr 03, 2024 | 4.71 | 4.769 | 4.595 | 4.73 | 3.059M |
Apr 02, 2024 | 4.95 | 5.01 | 4.68 | 4.69 | 4.211M |
Apr 01, 2024 | 5.04 | 5.09 | 4.905 | 5.05 | 4.875M |
Mar 28, 2024 | 5.20 | 5.34 | 5.06 | 5.08 | 3.491M |
Mar 27, 2024 | 5.04 | 5.208 | 4.97 | 5.15 | 2.990M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.585
Minimum
Nov 14 2019
19.76
Maximum
Feb 16 2022
8.363
Average
7.60
Median
Aug 04 2023
Price Benchmarks
AIM ImmunoTech Inc | 0.39 |
Perspective Therapeutics Inc | 1.70 |
Protalix BioTherapeutics Inc | 1.21 |
Electromed Inc | 17.65 |
Armata Pharmaceuticals Inc | 2.40 |
Price Related Metrics
PS Ratio | 2.650 |
Earnings Yield | -25.82% |
Market Cap | 942.10M |